Venetoclax: A new wave in hematooncology-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Venetoclax: A new wave in hematooncology

Published:2018-05 Issue: Volume:61 Page:10-25
ISSN:0301-472X
Container-title:Experimental Hematology
language:en
Short-container-title:Experimental Hematology

Author:

Mihalyova Jana,Jelinek Tomas,Growkova Katerina,Hrdinka Matous,Simicek Michal,Hajek Roman

Funder

Ministry of Health

Institutional Development Plan of University of Ostrava

Strengthening International Cooperation in Science, Research and Education

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Genetics,Hematology,Molecular Biology

Reference131 articles.

1. Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells;Fink;Infect Immun,2005

2. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics;Kerr;Br J Cancer,1972

3. The Bcl2 family: regulators of the cellular life-or-death switch;Cory;Nat Rev Cancer,2002

4. The hallmarks of cancer;Hanahan;Cell,2000

5. Activation of Fas by FasL induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-xL;Huang;Proc Natl Acad Sci USA,1999

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Directly targeting BAX for drug discovery: Therapeutic opportunities and challenges;Acta Pharmaceutica Sinica B;2024-06

2. The Safety of Novel Therapies in Chronic Lymphocytic Leukemia in the Era of Intermittent Fasting: A Pharmacology-Based Review;Cancers;2024-05-30

3. COVID-19 severity in patients with chronic lymphocytic leukemia treated with venetoclax: a single-center observational cohort study;Annals of Hematology;2024-04-18

4. A Novel Approach for Glioblastoma Treatment by Combining Apoptosis Inducers (TMZ, MTX, and Cytarabine) with E.V.A. (Eltanexor, Venetoclax, and A1210477) Inhibiting XPO1, Bcl-2, and Mcl-1;Cells;2024-04-04

5. Cardiovascular Toxicity of Antineoplastic Treatments in Hematological Diseases: Focus on Molecular Mechanisms to Improve Therapeutic Management;Journal of Clinical Medicine;2024-03-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3